AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 66 filers reported holding AVROBIO INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $3,402,000 | +7.1% | 244,032 | 0.0% | 0.08% | -33.6% |
| Q3 2020 | $3,177,000 | -42.7% | 244,032 | -23.2% | 0.12% | -42.2% |
| Q2 2020 | $5,542,000 | +12.1% | 317,579 | 0.0% | 0.21% | -8.3% |
| Q1 2020 | $4,942,000 | -22.7% | 317,579 | 0.0% | 0.23% | -9.8% |
| Q4 2019 | $6,393,000 | -20.3% | 317,579 | -44.1% | 0.26% | -47.7% |
| Q3 2019 | $8,024,000 | +79.4% | 568,294 | +106.7% | 0.49% | +89.9% |
| Q2 2019 | $4,472,000 | -32.4% | 275,000 | -8.3% | 0.26% | -42.5% |
| Q1 2019 | $6,615,000 | -70.7% | 300,000 | -77.9% | 0.45% | -75.6% |
| Q4 2018 | $22,607,000 | -70.8% | 1,357,784 | -9.0% | 1.84% | -63.5% |
| Q3 2018 | $77,431,000 | +79.8% | 1,492,784 | -1.0% | 5.03% | +57.9% |
| Q2 2018 | $43,062,000 | – | 1,507,783 | – | 3.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,736,027 | $45,555,000 | 28.05% |
| Aisling Capital Management LP | 736,998 | $12,271,000 | 12.93% |
| Cormorant Asset Management, LP | 1,357,784 | $22,607,000 | 1.84% |
| New Leaf Venture Partners, L.L.C. | 215,550 | $3,589,000 | 0.98% |
| Eventide Asset Management | 928,891 | $14,901,000 | 0.66% |
| EMERALD ADVISERS, LLC | 380,636 | $6,338,000 | 0.31% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 372,865 | $6,208,000 | 0.29% |
| Blackstone Inc. | 2,962,325 | $49,323,000 | 0.28% |
| PFM Health Sciences, LP | 241,413 | $4,020,000 | 0.11% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 143,762 | $2,394,000 | 0.10% |